• Citer

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

par Buisseret, Laurence ;Loirat, Delphine;Aftimos, Philippe ;Maurer, Christian;Punie, Kevin;Debien, Véronique;Kristanto, Paulus;Eiger, Daniel;Goncalves, Anthony;Ghiringhelli, François;Taylor, Donatienne;Clatot, Florent;Van den Mooter, Tom;Ferrero, Jean Marc;Bonnefoi, Herve;Canon, Jean-Luc;Duhoux, Francois P;Mansi, Laura;Poncin, Renaud;Barthélémy, Philippe;Isambert, Nicolas;Denis, Zoe;Catteau, Xavier ;Salgado, Roberto;Agostinetto, Elisa;de Azambuja, Evandro ;Rothé, Françoise;Craciun, Ligia;Venet, David ;Romano, Emanuela;Stagg, John;Paesmans, Marianne ;Larsimont, Denis ;Sotiriou, Christos ;Ignatiadis, Michail ;Piccart-Gebhart, Martine
Référence Nature communications, 14, 1, page (7018)
Publication Publié, 2023-11-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Auteur:	Buisseret, Laurence; Loirat, Delphine; Aftimos, Philippe; Maurer, Christian; Punie, Kevin; Debien, Véronique; Kristanto, Paulus; Eiger, Daniel; Goncalves, Anthony; Ghiringhelli, François; Taylor, Donatienne; Clatot, Florent; Van den Mooter, Tom; Ferrero, Jean Marc; Bonnefoi, Herve; Canon, Jean-Luc; Duhoux, Francois P; Mansi, Laura; Poncin, Renaud; Barthélémy, Philippe; Isambert, Nicolas; Denis, Zoe; Catteau, Xavier; Salgado, Roberto; Agostinetto, Elisa; de Azambuja, Evandro; Rothé, Françoise; Craciun, Ligia; Venet, David; Romano, Emanuela; Stagg, John; Paesmans, Marianne; Larsimont, Denis; Sotiriou, Christos; Ignatiadis, Michail; Piccart-Gebhart, Martine
Informations sur la publication:	Nature communications, 14, 1, page (7018)
Statut de publication:	Publié, 2023-11-01
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Female
	Humans
	Antineoplastic Agents -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Carboplatin -- therapeutic use
	Paclitaxel -- therapeutic use
	Triple Negative Breast Neoplasms -- drug therapy -- pathology
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2041-1723
	info:doi/10.1038/s41467-023-42744-y
	info:pii/10.1038/s41467-023-42744-y
	info:scp/85175700029
	info:pmid/37919269
	PMC10622534